AIM2 and infection: Finally, in vivo therapeutic experiments demonstrated that oligonucleotide-mediated inhibition of AIM2 in CAST/EiJ mice increased survival and attenuated proinflammatory cytokine production, cell death, and tissue damage following MPXV infection.